Apogee Therapeutics, Inc. · NASDAQ:APGE
Dambkowski Carl disposed of 168,498 Apogee Therapeutics, Inc. shares (Form 4)
Traded Sep 2 to Sep 3, 2026 · Filed Sep 3, 2026
From Sep 2 to Sep 3, 2026, Dambkowski Carl (Chief Medical Officer) disposed of 168,498 Apogee Therapeutics, Inc. shares at US$135.06 for US$186K, leaving 0 shares. Filed Sep 3, 2026 (Form 4).
- Disposed of
- 168,498 shares
- Price
- US$135.06
- Value
- US$186K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Disposition | 1,375 | US$135.06 | 167,123 | Direct |
| Sep 3, 2026 | Common Stock | Disposition | 167,123 | 0 | Direct |
Source
Related
- Apogee Therapeutics, Inc.
- Dambkowski Carl
- Apogee Therapeutics, Inc. shareholders
- Form 4 · Dambkowski Carl · Aug 7, 2026
- Form 4 · Dambkowski Carl · Jul 16, 2026
- Form 4 · Dambkowski Carl · Jul 2, 2026
- Form 4 · Dambkowski Carl · Jun 24, 2026
- Form 4 · Dambkowski Carl · Jun 5, 2026
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Fox Jennifer A. · Sep 3, 2026